99 related articles for article (PubMed ID: 3074011)
1. Taxonomic specificity of restriction-modification enzymes.
Janulaitis A; Kazlauskiene R; Lazareviciute L; Gilvonauskaite R; Steponaviciene D; Jagelavicius M; Petrusyte M; Bitinaite J; Vezeviciute Z; Kiuduliene E
Gene; 1988 Dec; 74(1):229-32. PubMed ID: 3074011
[No Abstract] [Full Text] [Related]
2. Aminoglycoside inactivating enzymes produced by R plasmids of Escherichia coli, Citrobacter freundii, Klebsiella pneumoniae, Proteus vulgaris, Providencia stuartii and Serratia marcescens.
Gómez-Lus R; Rubio Calvo MC; Mur LL
J Antimicrob Chemother; 1977 Nov; 3 Suppl C():39-41. PubMed ID: 340445
[No Abstract] [Full Text] [Related]
3. [Real-time PCR for fast detection of plasmid-mediated qnr genes in extended spectrum beta-lactamase producing Enterobacteriaceae].
Guillard T; Cavallo JD; Cambau E; Duval V; Bajolet O; Brasme L; de Champs C; Vernet-Garnier V
Pathol Biol (Paris); 2010 Dec; 58(6):430-3. PubMed ID: 19375248
[TBL] [Abstract][Full Text] [Related]
4. Distribution and diversity of hsd genes in Escherichia coli and other enteric bacteria.
Daniel AS; Fuller-Pace FV; Legge DM; Murray NE
J Bacteriol; 1988 Apr; 170(4):1775-82. PubMed ID: 2832380
[TBL] [Abstract][Full Text] [Related]
5. KpnAI, a new type I restriction-modification system in Klebsiella pneumoniae.
Lee NS; Rutebuka O; Arakawa T; Bickle TA; Ryu J
J Mol Biol; 1997 Aug; 271(3):342-8. PubMed ID: 9268663
[TBL] [Abstract][Full Text] [Related]
6. Immunological relationships of bacterial L-asparaginases.
Bascomb S; Bettelheim KA
J Gen Microbiol; 1976 Jan; 92(1):175-82. PubMed ID: 54404
[TBL] [Abstract][Full Text] [Related]
7. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.
Nordmann P; Poirel L
Clin Microbiol Infect; 2014 Sep; 20(9):821-30. PubMed ID: 24930781
[TBL] [Abstract][Full Text] [Related]
8. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
Jayol A; Poirel L; Dortet L; Nordmann P
Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
10. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
Koh TH; Sng LH; Wang G; Hsu LY; Lin RT; Tee NW
Int J Antimicrob Agents; 2007 Sep; 30(3):278-80. PubMed ID: 17587551
[No Abstract] [Full Text] [Related]
11. Families of restriction enzymes: an analysis prompted by molecular and genetic data for type ID restriction and modification systems.
Titheradge AJ; King J; Ryu J; Murray NE
Nucleic Acids Res; 2001 Oct; 29(20):4195-205. PubMed ID: 11600708
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of extended-spectrum beta-lactamases of the CTX-M type producing Escherichia coli and Klebsiella pneumoniae in Bretonneau hospitals (CHRU Tours)].
Holstein A; Grillon A; Yzon L; Morange V; Baty G; Lartigue MF; Mereghetti L; Goudeau A; Lanotte P
Pathol Biol (Paris); 2010 Feb; 58(1):67-9. PubMed ID: 19892477
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.
Yoo JS; Byeon J; Yang J; Yoo JI; Chung GT; Lee YS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):261-5. PubMed ID: 20462727
[TBL] [Abstract][Full Text] [Related]
14. Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14.
Mataseje LF; Boyd DA; Fuller J; Haldane D; Hoang L; Lefebvre B; Melano RG; Poutanen S; Van Caeseele P; Mulvey MR
J Antimicrob Chemother; 2018 Mar; 73(3):626-633. PubMed ID: 29272439
[TBL] [Abstract][Full Text] [Related]
15. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France.
Lartigue MF; Poirel L; Nordmann P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4929-30. PubMed ID: 15561885
[No Abstract] [Full Text] [Related]
16. beta-Lactamase bioassay: a simplified method to determine extended-spectrum beta-lactamases (ESBL) in enterobacteria.
Silva-Sánchez J; Aguilar-Zacarías C
Arch Med Res; 1997; 28(2):285-7. PubMed ID: 9204623
[TBL] [Abstract][Full Text] [Related]
17. [DNA restriction-modification systems].
Glatman LI; Kravets AN
Antibiot Khimioter; 1989 Dec; 34(12):932-8. PubMed ID: 2560908
[No Abstract] [Full Text] [Related]
18. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
19. [Detection of extended-spectrum beta-lactamases by the rapid ATB E technique. Value of the API V2.1.1 expert system].
Hirtz P; Recule C; Le Noc P; Sirot D; Croize J
Pathol Biol (Paris); 1992 May; 40(5):551-5. PubMed ID: 1495843
[TBL] [Abstract][Full Text] [Related]
20. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Vourli S; Giakkoupi P; Miriagou V; Tzelepi E; Vatopoulos AC; Tzouvelekis LS
FEMS Microbiol Lett; 2004 May; 234(2):209-13. PubMed ID: 15135524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
